Paper40947720
Pompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management.
Adadi N and 1 other. Curr Cardiol Rev, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Pompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management. Papers, record 40947720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40947720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycogen Storage Disease Type II | Major topic |
| alpha-Glucosidases | Major topic |
| Enzyme Replacement Therapy | Major topic |
| Genetic Therapy | Major topic |
| Humans | |
| Mutation | |
| Disease Management |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31510962 | Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand. | BMC Med Genet | 2019 | https://conductscience.org/library/papers/31510962 | PubMed |
| 2 | 32012848 | Novel Mutations Found in Individuals with Adult-Onset Pompe Disease. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32012848 | PubMed |
| 3 | 28869276 | Amniocentesis and chorionic villus sampling for prenatal diagnosis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28869276 | PubMed |
| 4 | 37600231 | GAA variants associated with reduced enzymatic activity but lack of Pompe-related symptoms, incidentally identified by exome sequencing. | Mol Genet Metab Rep | 2023 | https://conductscience.org/library/papers/37600231 | PubMed |
| 5 | 35264382 | Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment. | BMJ Case Rep | 2022 | https://conductscience.org/library/papers/35264382 | PubMed |
| 6 | 39020349 | Enzyme replacement therapy and immunotherapy lead to significant functional improvement in two children with Pompe disease: a case report. | J Med Case Rep | 2024 | https://conductscience.org/library/papers/39020349 | PubMed |
| 7 | 35878795 | Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35878795 | PubMed |
| 8 | 37639402 | Current avenues of gene therapy in Pompe disease. | Curr Opin Neurol | 2023 | https://conductscience.org/library/papers/37639402 | PubMed |
| 9 | 29451150 | Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease. | Chin Med J (Engl) | 2018 | https://conductscience.org/library/papers/29451150 | PubMed |
| 10 | 35123877 | Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening. | Mol Genet Metab | 2022 | https://conductscience.org/library/papers/35123877 | PubMed |
| 11 | 31228295 | Gene-specific features enhance interpretation of mutational impact on acid α-glucosidase enzyme activity. | Hum Mutat | 2019 | https://conductscience.org/library/papers/31228295 | PubMed |
| 12 | 34362174 | New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside. | J Clin Med | 2021 | https://conductscience.org/library/papers/34362174 | PubMed |
| 13 | 38057636 | Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). | J Neurol | 2024 | https://conductscience.org/library/papers/38057636 | PubMed |
| 14 | 36428004 | Retrospective analysis of prenatal ultrasound of children with Pompe disease. | Taiwan J Obstet Gynecol | 2022 | https://conductscience.org/library/papers/36428004 | PubMed |
| 15 | 24150945 | Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24150945 | PubMed |
| 16 | 36411466 | Infantile Pompe disease with intrauterine onset: a case report and literature review. | Ital J Pediatr | 2022 | https://conductscience.org/library/papers/36411466 | PubMed |
| 17 | 31392190 | Molecular genetics of Pompe disease: a comprehensive overview. | Ann Transl Med | 2019 | https://conductscience.org/library/papers/31392190 | PubMed |
| 18 | 22616199 | Genetic counseling in Pompe disease. | Acta Myol | 2011 | https://conductscience.org/library/papers/22616199 | PubMed |
| 19 | 30922962 | A genetic modifier of symptom onset in Pompe disease. | EBioMedicine | 2019 | https://conductscience.org/library/papers/30922962 | PubMed |
| 20 | 36969713 | Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview. | Curr Treat Options Neurol | 2022 | https://conductscience.org/library/papers/36969713 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41898889 | Genetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/41898889 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GAA | 2548 | PubTator's text mining | https://conductscience.org/library/genes/2548 | NCBI Gene |
| SI | 6476 | PubTator's text mining | https://conductscience.org/library/genes/6476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40947720
GET https://conductscience.org/api/papers/v1/40947720/references?page=2